Aphria's Approved Growing Space Doubles

Combined Facility Capable of Generating an Estimated $30 Million a Year

 

 

LEAMINGTON, ONTARIO--(Marketwired - Feb. 12, 2016) -

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH) is pleased to announce that the Company has received a license from Health Canada for the production of cannabis under the Marihuana for Medical Purposes Regulations (Canada) ("MMPR") for its new Part 1 expansion in Leamington, Ontario.

Under the MMPR, the license amendment provides Aphria with additional production space of 22,000 square feet. In addition, over 7,000 square feet of additional infrastructure, including the Company's oil extraction room, chemistry laboratory and microbiology laboratory were approved. The Company anticipates its licensed capacity to increase over time as production and sales continue to grow. Based on new growing technologies added at the same time as the expansion, the

...
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.